Depression as well as stress are serious mental health difficulties, each of which are amazingly dangerous to the person in the worst of times and seriously disruptive at the very best of times. There are a dizzying array of treatments that are available for both, each with extremely varying levels of effectiveness determined by the person. Nonetheless, it might surprise you that some researchers have advocated treating these illnesses with little amounts of hallucinogenic drugs, as reported by Motherboard.
Though it might seem counterintuitive to take a strong hallucinogen as a way to decrease the indications of stress, taking a tiny dose of LSD – one tenth of a standard dose (10-20 micrograms, as opposed to 100-200 micrograms) – every four days is seemingly an effective treatment. If that is done accurately, the user will not detect a slow down in their cognitive capabilities, and have any traumatic experiences, is not going to experience hallucinations – based on research that is true fairly small.
James Fadiman, a psychologist known for his wide-ranging research into psychedelic drugs, is a proponent of the treatment, also called “microdosing.” He told Motherboard: “Folks do it and they are eating better, sleeping better, they are frequently returning to exercise or yoga or meditation.
Five years back, an experiment was ran by Fadiman.
These “trip reports” were sent back in their hundreds, as well as the answers were overwhelmingly favorable. “This is absolute guesswork, but so numerous states who I have seen are enhanced, it seems like it rebalances those pistons that are not in equilibrium,” he added. “This could be in your central nervous system, it might be the brain stem, it might be that it is enhancing function of mitochondria.” Just five of the reports that were returned noted a negative encounter. Additionally, others say that after a span of microdosing, they change back to being seriously concerned or depressed.
Fadiman released a pioneering study in 1966 back on the purported advantages of hallucinogens, particularly investigating the effects they have on creative problem solving – he is definitely a specialist on microdosing. But this research area is very small, not least because experiments on people who have prohibited drugs is a notoriously tough sell. Fadiman expects that, earlier instead of after, appropriate scientific trials – as opposed to his “field studies” – is going to be run on microdosing, with all the longterm aim of obtaining acceptance from the Food and Drug Administration (FDA).
It cannot be stressed enough the self-administration of psychedelic drugs to treat mental health disorders, especially without having any peer reviewed studies to support this system, could be significantly dangerous. Users are in danger of taking an unintentionally strong dose of a drug like LSD, as well as the present evidence of their effectiveness as a treatment for all these illnesses is anecdotal and circumstantial.